Patient equity and respiratory syncytial virus Immunoprophylaxis
Abstract An analysis of benefit and cost is critical for independent advisory groups that provide evidence-based recommendations. In many countries, the role of RSV immunoprophylaxis for infants at increased risk of hospitalization is controversial because of limited benefit and high cost. The repor...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2019-01-01
|
| Series: | Israel Journal of Health Policy Research |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s13584-019-0288-6 |